A

Aveo Pharmaceuticals Inc
F:VPA1

Watchlist Manager
Aveo Pharmaceuticals Inc
F:VPA1
Watchlist
Price: 13.77 EUR -0.4%
Market Cap: 478.7m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of VPA1.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VPA1 Intrinsic Value
Not Available
A
Base Case Scenario
Compare VPA1 to

Fundamental Analysis

Aveo Pharmaceuticals Inc
F:VPA1
US
Biotechnology
Market Cap
476.7m EUR
IPO
Mar 12, 2010
US
Biotechnology
Market Cap
476.7m EUR
IPO
Mar 12, 2010
Price
€false
EPS
$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VPA1?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Aveo Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aveo Pharmaceuticals Inc

Current Assets 100.7m
Cash & Short-Term Investments 77.4m
Receivables 19.8m
Other Current Assets 3.6m
Non-Current Assets 502k
PP&E 257k
Other Non-Current Assets 245k
Efficiency

Free Cash Flow Analysis
Aveo Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aveo Pharmaceuticals Inc

Revenue
94.3m USD
Cost of Revenue
-11.5m USD
Gross Profit
82.8m USD
Operating Expenses
-107.3m USD
Operating Income
-24.5m USD
Other Expenses
-4.5m USD
Net Income
-29m USD
Fundamental Scores

VPA1 Profitability Score
Profitability Due Diligence

Aveo Pharmaceuticals Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

26/100
Profitability
Score

Aveo Pharmaceuticals Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

VPA1 Solvency Score
Solvency Due Diligence

Aveo Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
Low D/E
38/100
Solvency
Score

Aveo Pharmaceuticals Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VPA1 Price Targets Summary
Aveo Pharmaceuticals Inc

There are no price targets for VPA1.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VPA1 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y